Skip to content

The effect of exercise on muscle mass and strength in elderly diabetics with muscle weakness

Identifying a Biomarker Panel for Diabetic Sarcopenia Based on their Differential Expression after Resistance Training - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084645
Enrollment
20
Registered
2025-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M625- Muscle wasting and atrophy, not elsewhere classified

Interventions

Intervention1: Resistance training programme: It composed of 4 days training in a week for 8 weeks.the duration is 30 minutes per day.A certified gym trainer will be training the subjects . This has b

Sponsors

Dr Aiswarya.P
Lead Sponsor
Dr V K Sashindaran
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: All the individuals with type 2 diabetes mellitus with sarcopenia attending, K.S Hegde Medical Academy, Rural health center Ira more than 40 years of age of either sex and willing to participate in the study Diabetes defined as those patients with fasting glucose levels of greater than equal to 126 mg/dl or random blood glucose greater than equal to 200 mg/dl, HbA1c greater than equal to 6.5%. Sarcopenia as defined by EWGSOP SARC F less than 4 or Hand Grip Strength less than27 kg for males ,less than 18 kg for females.

Exclusion criteria

Exclusion criteria: Known cases of physical disabilities, chronic disease (tuberculosis, cancer, chronic renal failure and ischemic heart disease), muscular dystrophies, joint injuries ,patients on insulin therapy,

Design outcomes

Primary

MeasureTime frame
Biomarkers-coenzyme Q,Irisin, myostatin/follistatin ratio,BDNF,P3NP , miR1/206, miR 21, miR 23a, miR27a,/27b,miR29b-3p, miR 129-5P miR133a3P, miR 214, miR 486a-5pTimepoint: Biomarkers-coenzyme Q,Irisin, myostatin/follistatin ratio,BDNF,P3NP , miR1/206, miR 21, miR 23a, miR27a,/27b,miR29b-3p, miR 129-5P miR133a3P, miR 214, miR 486a-5p

Secondary

MeasureTime frame
Comparison of the biomarkers before and after interventionTimepoint: Comparison of the biomarkers after 8 weeks of intervention

Countries

India

Contacts

Public ContactDr VK Sashindaran

K.S Hegde Medical Academy Nitte DU

vksashindran@gmail.com9958826493

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026